WASHINGTON — It’s been five years since Congress gave the Food and Drug Administration sweeping authority to regulate compounding, but lawmakers — many of whom wrote that law — still don’t think the FDA is properly regulating the growing industry. The problem is, lawmakers can’t seem to agree on the tack the agency should take.

And they’re not the only ones pulling the FDA in different directions.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Proposterous! And misleading at best. How long will you constantly be pivoting for your self interests all the while attempting to maintain a semblance of neutrality? Compounders are the hidden gems and an essential in the world of alternative/designer preparations for those out of the box clinicians who want to travel the extra mile in service to the needs of the patient instead of simply towing the party line with the commercial interests. The vast majority of compounders and their labs are scrutinized by the FDA and state boards at rates far higher than existing big pharma labs to ensure compliance levels above and beyond reproach. This ‘ramping up business’ is self-delusional, politics, cronyism and indulgent reproachful feeding at the troughs of pig pharma.

  • Most FDA approved drugs could kill me due to corn and milk allergens in them, so I need compounds without the allergens. Two of the drugs I take do not have appropriate doses or forms and must be compounded. There are no FDA-approved drugs for 2 of the conditions I have, but some of the 503a and 503b bulk compinfing substances can help me, though the FDA is trying to ban them…and then there will be notning to take.

    I need compounds. Even my insurance company agrees I do. There are laws that cover safety today. I use compounders my doctor and I trust.

    The FDA has no business getting between me and my doctor and keeping me from getting substances that treat my serious illness. They have already banned multiple substances that are useful in my care without eben considering the conditions my doctor is prescribing them for.

    I am scared that there will not be compounds available to treat me and I could die as a result.

  • I have almost 40 years experience in pharma manufacturing and qc. There are few controls governing batch uniformity and dose uniformity, particularly for capsule dosage forms. My recent experience with a tricomponent antibiotic-antimicrobial-antifungal customer compounding was disastrous.

Comments are closed.

Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy